2022年全球癌症数据统计于近期发布.该文立足于国际癌症研究机构(International Agency for Research on Cancer,IARC)最新的GLOBCAN数据,系统性分析全球185个国家36种癌症的发病和死亡情况.国际癌症负担在未来30年将继续加重,已成为包括中国等诸多国家面临的严峻公共卫生问题及社会问题.本文对全球最新癌症流行病学数据要点进行解读,关注癌症流行病学演变进程及未来发展趋势,旨在开阔肿瘤防治的国际视野,以期对我国肿瘤防治工作提供参考和指导.
Interpretation of the key points of"Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"
"Global cancer statistics 2022"based on the latest GLOBCAN data from the International Agency for Research on Cancer(IARC)was recently released,providing a systematic analysis of the incidence and mortality of 36 types of cancer across 185 countries worldwide.The international burden of cancer is expected to continue to increase over the next 30 years,posing a severe public health and social challenge for many countries,including China.This article offers a key point interpretation of the"Global cancer statistics 2022",focusing on the evolution of cancer epidemiology and future development trends.The aim is to broaden the international perspective on cancer prevention and treatment,with the hope of providing reference and guidance for cancer prevention and treatment efforts in our country.
Cancerglobal cancer burdencancer incidencecancer mortality
NETL
NSTL
万方数据
